Published in Gut on November 01, 2005
Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis. Hum Mutat (2006) 1.80
Increased activation of hereditary pancreatitis-associated human cationic trypsinogen mutants in presence of chymotrypsin C. J Biol Chem (2012) 1.29
Human cationic trypsinogen (PRSS1) variants and chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol (2014) 0.92
Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet (1996) 7.94
SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology (2000) 4.62
Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med (1998) 3.91
Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology (1997) 2.84
Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol (2004) 2.82
Mutations in exons 2 and 3 of the cationic trypsinogen gene in Japanese families with hereditary pancreatitis. Gut (1999) 2.51
The molecular evolution of the vertebrate trypsinogens. J Mol Evol (1997) 1.20
The First International Symposium on Hereditary Pancreatitis. Pancreas (1999) 0.93
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer (2008) 3.87
A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature (1994) 3.87
Prognostic factors and survival in children with perinatal HIV-1 infection. The Italian Register for HIV Infections in Children. Lancet (1992) 3.52
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet (2000) 3.50
Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature (1994) 3.46
Mutations in ribosomal protein S19 gene and diamond blackfan anemia: wide variations in phenotypic expression. Blood (1999) 2.07
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet (2005) 1.91
Somatotopic activation of opioid systems by target-directed expectations of analgesia. J Neurosci (1999) 1.81
Chronic pancreatitis: report from a multicenter Italian survey (PanCroInfAISP) on 893 patients. Dig Liver Dis (2008) 1.74
The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells. Br J Dermatol (2001) 1.70
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study. Ann Oncol (2009) 1.55
Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma. Clin Radiol (2006) 1.52
Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients. Am J Pathol (1999) 1.47
Cold snare excision of small colorectal polyps. Gastrointest Endosc (1992) 1.46
Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group. Ital J Gastroenterol Hepatol (1999) 1.42
Monoethyl glycine xylidide (MEGX) test evaluation in primary biliary cirrhosis: comparison with Mayo score. Eur J Gastroenterol Hepatol (1997) 1.42
Percutaneous transhepatic sphincterotomy--a report on 3 cases. Endoscopy (1991) 1.41
Mitochondrial DNA polymorphism in four Sardinian villages. Ann Hum Genet (1988) 1.39
Cancer genetic counselling. Ann Oncol (2005) 1.38
Endoscopic endonasal transsphenoidal approach: outcome analysis of 100 consecutive procedures. Minim Invasive Neurosurg (2002) 1.35
A genetic history of Italy. Ann Hum Genet (1988) 1.33
Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors. Lab Invest (2001) 1.26
Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg (1997) 1.22
Primary empty sella: Why and when to investigate hypothalamic-pituitary function. J Endocrinol Invest (2010) 1.21
Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online. Hum Mutat (1998) 1.19
Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience. Langenbecks Arch Surg (2008) 1.19
Vaginal and endocervical microorganisms in symptomatic and asymptomatic non-pregnant females: risk factors and rates of occurrence. Clin Microbiol Infect (2009) 1.16
Intracranial meningiomas: correlations between MR imaging and histology. Eur J Radiol (1999) 1.14
The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma. Mol Cell Biol (1996) 1.09
No effect of long-term treatment with pancreatic extract on recurrent abdominal pain in patients with chronic pancreatitis. Scand J Gastroenterol (1995) 1.09
RET activation by germline MEN2A and MEN2B mutations. Oncogene (1995) 1.07
Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients. J Clin Endocrinol Metab (2000) 1.07
Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. J Clin Endocrinol Metab (2001) 1.07
Experimental acute pancreatitis induced by platelet activating factor in rabbits. Am J Pathol (1989) 1.06
Possible role of aldehydic lipid peroxidation products as chemoattractants. Int J Tissue React (1987) 1.05
Does the default-mode functional connectivity of the brain correlate with working-memory performances? Arch Ital Biol (2009) 1.04
Identification of Shc docking site on Ret tyrosine kinase. Oncogene (1997) 1.04
Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours. Clin Radiol (2008) 1.03
A large TSC2 and PKD1 gene deletion is associated with renal and extrarenal signs of autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (1997) 1.03
The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res (2002) 1.02
Intracranial lipomas. Diagnostic and therapeutic considerations. J Neurosurg Sci (1989) 1.02
Development of "de novo" aneurysms following endovascular procedures. Neuroradiology (2002) 1.02
Supratentorial cavernous malformations and epilepsy: seizure outcome after lesionectomy on a series of 35 patients. Clin Neurol Neurosurg (1997) 1.01
Frequency of RET mutations in long- and short-segment Hirschsprung disease. Hum Mutat (1997) 1.01
Close linkage with the RET protooncogene and boundaries of deletion mutations in autosomal dominant Hirschsprung disease. Hum Mol Genet (1993) 1.00
A family with autosomal dominant leukodystrophy linked to 5q23.2-q23.3 without lamin B1 mutations. Eur J Neurol (2009) 0.99
Endoscopic diagnosis and treatment of gastric bezoars. Gastrointest Endosc (1998) 0.98
Lipoma of the sylvian region. Clin Neurol Neurosurg (1989) 0.98
Interleukin 3 stimulates proliferation and triggers endothelial-leukocyte adhesion molecule 1 gene activation of human endothelial cells. J Clin Invest (1993) 0.97
Combined first-stage hepatectomy and colorectal resection in a two-stage hepatectomy strategy for bilobar synchronous liver metastases. Br J Surg (2010) 0.97
Stress, sexual dysfunctions, and male infertility. J Endocrinol Invest (2003) 0.96
Nosocomial infections in pediatric cardiac surgery, Italy. Infect Control Hosp Epidemiol (2001) 0.96
Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage. J Clin Endocrinol Metab (1997) 0.95
FMR1 gene premutation is a frequent genetic cause of late-onset sporadic cerebellar ataxia. Neurology (2005) 0.95
Small animal imaging facility: new perspectives for the radiologist. Radiol Med (2008) 0.94
Phase II trial of primary radiation therapy and concurrent chemotherapy for patients with locally advanced pancreatic cancer. Oncology (2005) 0.94
A novel family with Lamin B1 duplication associated with adult-onset leucoencephalopathy. J Neurol Neurosurg Psychiatry (2009) 0.94
Diamond-Blackfan anemia: report of seven further mutations in the RPS19 gene and evidence of mutation heterogeneity in the Italian population. Blood Cells Mol Dis (2000) 0.94
Interictal cortical reorganization in episodic migraine without aura: an event-related fMRI study during parametric trigeminal nociceptive stimulation. Neurol Sci (2011) 0.93
Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation. Oncogene (1998) 0.92
[Post-thyroidectomy cervical hematoma]. Minerva Chir (2005) 0.92
Cystic lesions associated with meningiomas. Surg Neurol (1986) 0.92
Defective function of Fas in patients with type 1 diabetes associated with other autoimmune diseases. Diabetes (2001) 0.91
Hemangioma of the temporal muscle. Head Neck (1996) 0.91
Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features. Ann Oncol (1998) 0.91
Pseudoaneurysm of the internal maxillary artery and Frey's syndrome after blunt facial trauma. J Oral Maxillofac Surg (1997) 0.91
Aerobic exercise prevents age-dependent cognitive decline and reduces anxiety-related behaviors in middle-aged and old rats. Neuroscience (2011) 0.91
Gelastic epilepsy: symptomatic and cryptogenic cases. Epilepsia (1999) 0.91
TSC1 and TSC2 deletions differ in size, preference for recombinatorial sequences, and location within the gene. Hum Genet (2001) 0.91
Dihydropteridine reductase deficiency: physical structure of the QDPR gene, identification of two new mutations and genotype-phenotype correlations. Hum Mutat (1998) 0.90
CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation. Br J Cancer (2001) 0.90
Arachnoid cyst of the quadrigeminal cistern. Neurochirurgia (Stuttg) (1986) 0.90
Exon structure and flanking intronic sequences of the human RET proto-oncogene. Biochem Biophys Res Commun (1993) 0.90
The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck. Oncogene (1997) 0.89
Venous angiomas and epilepsy. Neurol Sci (2000) 0.88
Dynamic contrast enhanced magnetic resonance imaging in monitoring bone metastases in breast cancer patients receiving bisphosphonates and endocrine therapy. Acta Radiol (2004) 0.88
MRI diagnosis of intramedullary metastases from extra-CNS tumors. Eur Radiol (1997) 0.88
Effect of different dopaminergic agents in the treatment of acromegaly. J Clin Endocrinol Metab (1997) 0.88
Widespread microstructural white matter involvement in amyotrophic lateral sclerosis: a whole-brain DTI study. AJNR Am J Neuroradiol (2012) 0.87
A novel missense mutation in fumarate hydratase in an Italian patient with a diffuse variant of cutaneous leiomyomatosis (Reed's syndrome). Dermatology (2010) 0.87
Heterogeneity and low detection rate of RET mutations in Hirschsprung disease. Eur J Hum Genet (1994) 0.85
Androgens and fertility. J Endocrinol Invest (2005) 0.85
Argyrophilic nucleolar organizer region counts in multiple myeloma: a histopathological study on bone marrow trephine biopsies. Virchows Arch A Pathol Anat Histopathol (1992) 0.85
The Glu632-Leu633 deletion in cysteine rich domain of Ret induces constitutive dimerization and alters the processing of the receptor protein. Oncogene (1999) 0.85
Texture features on T2-weighted magnetic resonance imaging: new potential biomarkers for prostate cancer aggressiveness. Phys Med Biol (2015) 0.85
High field functional MRI. Eur J Radiol (2003) 0.84
Percutaneous treatment (including pseudocystogastrostomy) of 74 pancreatic pseudocysts. Radiology (1989) 0.84
Pituitary macroadenoma and diaphragma sellae meningioma: differential diagnosis on MRI. Neuroradiology (1999) 0.84
Development of the laminated pattern of the chick tectum opticum. Int J Dev Neurosci (1995) 0.84
Fine mapping and cloning of the breakpoint associated with Menkes syndrome in a female patient. Genomics (1992) 0.84
Oxidative damage and transforming growth factor beta 1 expression in pretumoral and tumoral lesions of human intestine. Free Radic Biol Med (1997) 0.83